866-997-4948(US-Canada Toll Free)

Investigation Report on China Parecoxib Market, 2010-2019

Published By :

China Research and Intelligence Co., Ltd. (CRI)

Published Date : Jul 2015

Category :

Manufacturing, Packaging & Detailing

No. of Pages : 25 Pages

For a long time, opioid has been one of the main drugs for the treatment of moderate and severe pain following surgery. However, as people’s knowledge deepens, more and more doctors and patients come to realize that opioid is not really safe. Relevant studies show that opioid alone doesn’t work effectively on pain resulting from exercises and that is not conducive to postoperative exercise and recovery. Besides, the use of opioid after surgery can cause such side effects as nausea, vomiting, sedation and uroschesis which are dose-dependent. 

Parecoxib is a kind of COX-2 inhibitor which compared with opioid, can effectively inhibit COX-2 expression and reduce the synthesis of prostaglandin in the central and peripheral nervous system, inhibit hyperalgesia and increase pain threshold. Parecoxib’s analgesia has been confirmed in studies conducted by anesthesia department, department of orthopaedics, gynecology and general surgery department. And its combination of fast lasting pain relief and safety has made it a better choice for postoperational analgesia.

Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to enter Europe under the trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. 

Parecoxib develops fast after entering China in 2008. According to CRI’s market survey, its annual sales value rose from less than CNY 20 million in 2008 to over CNY 200 million in 2014 with CAGR during this period reaching 54.70%. Currently, parecoxib in the Chinese market is monopolized by Upjohn that brought in a sales value of CNY 204 million in 2014.

It is possible for local parecoxib to come into the market in the next few years. And the market size of parecoxib in China is expected to keep growing.

Readers can get at least the following information from this report:
  • market size of parecoxib in China
  • competitive landscape of parecoxib in Chinese market
  • price of parecoxib made by different enterprises in China
  • market outlook of parecoxib in China
suggests the following groups of people purchase this report:
  • manufacturers of analgesic
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

1 Related Concepts of Parecoxib
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Parecoxib in China
2.1 Patent and Approval Status of Parecoxib in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Parecoxib in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Parecoxib in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Parecoxib in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Parecoxib in Chinese Hospitals in 2014

7 Major Manufacturers of Parecoxib in Chinese Market, 2010-2014

8 Market Outlook of Parecoxib in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Chart


Chart Patent Status of Parecoxib in China
Chart Sales Status of Parecoxib in China
Chart Sales Value of Parecoxib in China, 2010-2014
Chart Sales Value of Parecoxib in Some Regions in China, 2010-2014
Chart Sales Volume of Parecoxib in China, 2010-2014
Chart Sales Volume of Parecoxib in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Parecoxib Made by Upjohn (US) in China, 2010-2014
Chart Sales Value and Market Share of Parecoxib Injections in China, 2010-2014
Chart Sales Volume and Market Share of Parecoxib Injections in China, 2010-2014
Chart Price of Parecoxib Made by Upjohn (US) in Some Chinese Cities in 2014

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *